International network and affiliated investigators

In CCBIO, we have extensive and increasing external collaboration. Activities such as international contacts and projects have been well established by all PIs.

Illustration of a doctor and a network of people all over the global map.

Photo:

www.colourbox.com

International affiliated researchers

In addition to standard project collaboration, CCBIO has a formalized international network based on employing high ranking researchers within various fields of cancer research in 10 % adjunct professor and researcher positions.

CCBIO’s rationale with this network is to establish an array of experienced advisors on scientific projects, collaborations, networking, and research strategy, as well as to perform joint research in the forefront and facilitate the transfer of knowledge.

Another important aim is to enable the CCBIO Research School for Cancer Studies to have research based courses on the highest level and to enable cosupervision and exchange of research and postdoctoral fellows.

In 2018, 13 highly ranked international affiliated investigators were employed in this network, and CCBIO has experienced good results in terms of fruitful collaboration and exchange of knowledge.

Please find below short bios about all our affiliated investigators.

Updated: 29.05.2019 (First published: 11.09.2017)

Frédéric Amant

Professor Frédéric Amant, PhD and MD, received his medical degree from the University of Leuven (KU Leuven), Belgium in 1992, completed his specialty training as an obstetrician/gynecologist in 1998, and his subspecialty training in gynecologic oncology in 2000.

Rameen Beroukhim

Rameen Beroukhim got his PhD at the University of Cambridge in 1996 and his MD at the University of California in 2000. He is currently a physician in the Department of Medical Oncology at the Dana-Farber Cancer Institute, an associate physician in medical oncology at Brigham and Women’s Hospital...

Jean-Christophe Bourdon

Dr. Jean-Christophe Bourdon earned his PhD in cellular and molecular biology in 1997 at the Paris XI University, France. He is currently senior lecturer at the School of Medicine at Dundee University. He was co-director of the Inserm- European Associated Laboratory (Toulouse University, France) in...

Rolf A. Brekken

Professor Rolf A. Brekken received his BA in biology from Luther College in Decorah, IA and his PhD from UT Southwestern Medical Center. His graduate studies were focused on developing novel therapies that target the vascular compartment of tumors.

Hani Gabra

Professor Hani Gabra took his medical degree at Glasgow University in 1987 and his PhD at Edinburgh University in 1996.

Jean Paul Thiery

Professor Jean Paul Thiery is a well-known researcher within the field of cancer therapeutics. Until July 2015 he was professor and head of the Department of Biochemistry of the Yong Loo Lin School of Medicine at the National University of Singapore (NUS). He also held a research director position...

Randolph Watnick

Dr. Watnick received his PhD in biochemistry and biophysics from Columbia University in 1999, and was a postdoctoral fellow with Dr. Robert Weinberg, Whitehead Institute, Cambridge, MA, until 2003.

Mark LaBarge

Mark LaBarge studied genetics at the University of California, Davis, and then earned his PhD in molecular pharmacology at Stanford University in 2004.M He is currently professor at the Department of Population Sciences, and deputy director of the Center for Cancer and Aging at the City of Hope...

Ritva Heljasvaara

Senior Researcher Ritva Heljasvaara received her PhD in 1996 in molecular biology at the University of Oulu, Finland. In 1998 she joined one of the world’s leading extracellular matrix (ECM) and collagen research groups led by Professor Taina Pihlajaniemi at the University of Oulu, and is currently...

Klaus Pantel

Professor Pantel did his MD at the University of Cologne in 1986, Dr. Med. at the University of Cologne in 1987 and Dr. Med. Habil. at the Ludwig-Maximillians-Universitaet in 1995. He is currently director of the Institute of Tumor Biology at the University Medical Center Hamburg-Eppendorf.

Therese Sørlie

Therese Sørlie got her PhD at the University of Oslo in 2000. She is currently currently head of the Department of Cancer Genetics, Institute for Cancer Research at Oslo University Hospital and adjunct professor at the University of Oslo, Medical Faculty.

Arne Östman

Professor Arne Östman received his PhD in 1990 on Plateletderived growth factor from the Ludwig Institute for Cancer Research, Uppsala University, Sweden. He is currently professor at the Karolinska Institute (KI).

Ian Mills

Ian Mills studied Biochemistry at the University of Oxford, and went on to earn his PhD in Molecular and Cellular Physiology at the University of Liverpool in 2000. He is currently Professor of Translational Prostate Cancer Biology at Queen’s University of Belfast and John Black Associate Professor...